Evidence map›Paper›PMID 41608733›Full record

ArticleNAR genomics and bioinformatics2026

SM3DD with segmented PCA: a comprehensive method for interpreting 3D spatial transcriptomics.

Tony Blick, Aaron Kilgallon, James Monkman, Caroline Cooper, Chin Wee Tan, Emily E Killingbeck, Liuliu Pan, Youngmi Kim, Yan Liang, Andy Nam and 10 more

Abstract read
In one paragraph

Article in NAR genomics and bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Tony BlickFrazer Institute, Faculty of Health, Medicine and Behavioural Sciences, The University of Queensland, Brisbane, QLD 4102, Australia.
Aaron KilgallonFrazer Institute, Faculty of Health, Medicine and Behavioural Sciences, The University of Queensland, Brisbane, QLD 4102, Australia.
James MonkmanFrazer Institute, Faculty of Health, Medicine and Behavioural Sciences, The University of Queensland, Brisbane, QLD 4102, Australia.
Caroline CooperFrazer Institute, Faculty of Health, Medicine and Behavioural Sciences, The University of Queensland, Brisbane, QLD 4102, Australia.
Chin Wee TanFrazer Institute, Faculty of Health, Medicine and Behavioural Sciences, The University of Queensland, Brisbane, QLD 4102, Australia.ORCID https://orcid.org/0000-0001-9695-7218
Emily E KillingbeckNanostring Technologies, Inc, Bruker Spatial Biology, Seattle, WA 98109, US.
Liuliu PanNanostring Technologies, Inc, Bruker Spatial Biology, Seattle, WA 98109, US.
Youngmi KimNanostring Technologies, Inc, Bruker Spatial Biology, Seattle, WA 98109, US.
Yan LiangNanostring Technologies, Inc, Bruker Spatial Biology, Seattle, WA 98109, US.
Andy NamNanostring Technologies, Inc, Bruker Spatial Biology, Seattle, WA 98109, US.
Michael LeonNanostring Technologies, Inc, Bruker Spatial Biology, Seattle, WA 98109, US.
Paulo S F GuimaraesPontifícia Universidade Católica do Paraná, PUCPR, Curitiba, Paraná 80215-901, Brazil.
Seigo NagashimaLaboratório de Patologia Experimental, PPGCS da PUCPR, Curitiba 80215-182, Brazil.
Ana P C MartinsLaboratório de Patologia Experimental, PPGCS da PUCPR, Curitiba 80215-182, Brazil.
Cleber Machado-SouzaFaculdades Pequeno Príncipe, Curitiba, Paraná 80230-020, Brazil.
Lucia de NoronhaLaboratório de Patologia Experimental, PPGCS da PUCPR, Curitiba 80215-182, Brazil.
John F FraserCritical Care Research Group, The Prince Charles Hospital, Brisbane 4032, Australia.
Gabrielle T BelzFrazer Institute, Faculty of Health, Medicine and Behavioural Sciences, The University of Queensland, Brisbane, QLD 4102, Australia.
Fernando Souza-Fonseca-GuimaraesFrazer Institute, Faculty of Health, Medicine and Behavioural Sciences, The University of Queensland, Brisbane, QLD 4102, Australia.
Arutha KulasingheFrazer Institute, Faculty of Health, Medicine and Behavioural Sciences, The University of Queensland, Brisbane, QLD 4102, Australia.ORCID https://orcid.org/0000-0003-3224-7350

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We developed Standardised Minimum 3D Distance (SM3DD), an entirely cell segmentation/annotation-free approach to the analysis of spatial RNA datasets, using it to compare lung tissue from 16 clinically normal individuals to that of 18 SARS-CoV-2 patients who died from acute respiratory distress syndrome. RNA spatial coordinates were determined using the CosMx™ Spatial Molecular Imager (Bruker Spatial Biology, US). For each individual transcript location, we calculated the three-dimensional distances to the nearest transcript of each transcript type, standardising the distances to each transcript type. Mean SM3DDs were compared between normal and SARS-CoV-2 patients. Notably, hierarchical clustering of the directional log10(P) values organized genes by functionality, making it easier to interpret biological contexts, and for FKBP11, where a decrease in distance to MZT2A was the most significant difference, suggesting a role in interferon signalling. Using a segmented principal components analysis of the entire SM3DD dataset, we identified multiple pathways, including 'SARS-CoV-2 infection', even though the assay did not include any SARS-CoV-2 transcripts.

Indexed as

COVID-19SARS-CoV-2HumansImaging, Three-DimensionalLungPrincipal Component AnalysisSpatial Transcriptomics

Identifiers

PMID41608733
PMCPMC12838529

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.